10 OUR GOVERNANCE
Rodriguez, it was part of the scientific program developed
by Prof. Alain Puisieux.
In terms of partnerships, in November the Executive Board
approved the creation of two Health Cooperation Groups (HCG) with the Institut Mutualiste Montsouris (IMM) in Paris, and the Institut Godinot (Cancer center of
Champagne-Ardenne and the southern Aisne region) in
Reims.
PURSUING STRATEGIC PLANS
In 2019 a discussion took place on the creation of an
Ethics Committee, reporting to the Supervisory Board.
Health and safety were also at the heart of the discussions during the second half of 2019, reiterating
their centrality to the work of every level at Institut Curie.
Concerning Europe, Institut Curie has begun networking with European leaders and has formed a working group on the institute s European strategy. Lastly, the major partnership agreements with INSERM, the French National Center for Scientific Research (CNRS) and the
French Ministry for Higher Education, Research and
Innovation, which formalize the role of the Institut Curie in cancer research on the national scale.
HIRING RELATED TO THE EXECUTIVE BOARD
2019 was marked by the arrival of Prof. Alain Puisieux as new Director of the Research Center. To strengthen its policies in terms of IT security and risk management,
Institut Curie hired an Information Systems Security
Manager and Data Protection Officer (RSSI-DPO) in
January, and created a position for an internal auditor, a new hiring that would report to the Executive Board.
HIGHLIGHTS
2019 also saw the start of negotiations as part of the
creation of Université PSL. The Executive Board wanted Institut Curie to be an associated member of PSL, in the same way as the Collège de France. Prof. Thierry
Philip and Prof. Alain Fuchs, President of Université PSL,
signed the agreement on November 28, in the presence of the Chairman of the Supervisory Board, Daniel Thierry.
In terms of social dialogue, 2019 featured discussions on the creation of new representative bodies (CSEE and
CSEC) and the organization of professional elections.
In June 2019, the Executive Board approved the
architectural plans for the Research Center on the Paris site, integrating a plan to extend the Pasteur building,
bringing the overall budget for the MC21 Research Center
property project from 11 million to 17 million.
In October, the Executive Board decided on a one-off support package of 1 million for the Hospital Group to develop translational research, and of 500,000 for the Medical-Scientific Program (MSP), led jointly by the
Hospital Group and the Research Center. It also approved
the creation of a Marie Curie Chair in Chemistry and
Biology on January 1, 2020. Awarded to Raphaël